Article
Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin.
Antimicrobial agents and chemotherapy - 1 Dec 2009
Locke Jeffrey B, Hilgers Mark, Shaw Karen Joy
Abstract excerpt
Following recent reports of ribosomal protein L3 mutations in laboratory-derived linezolid-resistant (LZD(r)) Staphylococcus aureus, we investigated whether similar mutations were present in LZD(r) staphylococci of clinical origin. Sequence analysis of a variety of LZD(r) isolates revealed two L3 mutations, DeltaSer145 (S. aureus NRS127) and Ala157Arg (Staphylococcus epidermidis 1653059), both occurring proximal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
